Breaking News Instant updates and real-time market news.

OPTN

Optinose

$6.74

-0.82 (-10.85%)

07:00
12/19/18
12/19
07:00
12/19/18
07:00

Optinose upside potential remains compelling, says Cantor Fitzgerald

Cantor Fitzgerald analyst Brandon Folkes says that despite a "lumpy" Xhance launch, he remains confident in the peak sales potential of Xhance. The "strong" efficacy data will drive uptake and persistence, even if this may take longer than originally anticipated, Folkes tells investors in a research note. The analyst believes upside potential in shares of Optinose "remains compelling" and he keeps an Overweight rating on the name with a $27 price target.

OPTN Optinose
$6.74

-0.82 (-10.85%)

11/14/18
CANT
11/14/18
NO CHANGE
Target $27
CANT
Overweight
Optinose price target lowered to $27 from $30 at Cantor Fitzgerald
Cantor Fitzgerald analyst William Tanner lowered his price target for Optinose to $27 to reflect tempered near-term expectations for Xhance. The analyst, however, still believes Xhance will become an important therapy for treating nasal polyps. He finds it reasonable that the drug "will deliver evidence of safety and efficacy in other indications that would meaningfully expand the commercial opportunity." Tanner reiterates an Overweight rating on Optinose.
10/17/18
JEFF
10/17/18
NO CHANGE
Target $31
JEFF
Buy
Jefferies still sees 'major' opportunity for Optinose after Dupixent data
Optinose (OPTN) shares underperformed yesterday following the positive Phase 3 results for Sanofi (SNY) and Regeneron's (REGN) Dupixent in treating patients with chronic rhinosinusitis with nasal polyps, Jefferies analyst David Steinberg tells investors in a research note titled "Biologics Competitor as Expected; Real World Pricing Issues Likely to Limit Us." The analyst says that while Dupixent demonstrated strong efficacy, clinicians he's spoken with believe that the "massive" pricing disparity versus nasal steroids will likely result in payer "step edits" that could limit widespread adoption of the "expensive" biologics currently under development. Further, Dupixent's head-to-head comparison with Optinose's Xhance's "strong" efficacy profile is difficult, the analyst adds. Steinberg still sees a "major" long-term opportunity for Xhance and keeps a Buy rating on Optinose with a $31 price target.
08/31/18
JEFF
08/31/18
NO CHANGE
Target $31
JEFF
Buy
Jefferies sees prescription rebound for Optinose's Xhance
After meeting with Optinose management, Jefferies analyst David Steinberg says that despite the recent setback, he continues to believe that Xhance will become a large product. Post adjustments to Xhance launch tactics, management believes they have made the proper changes and expect prescriptions to reaccelerate as summer ends, Steinberg tells investors in a research note. He points out that the company highlighted positive physician and patient feedback on the performance of the drug. The analyst keeps a Buy rating on Optinose with a $31 price target.
08/14/18
PIPR
08/14/18
NO CHANGE
Target $30
PIPR
Overweight
Piper not worried by trajectory of Optinose's Xhance, stays Overweight
Piper Jaffray analyst David Amsellem says he's not worried about the growth trajectory of Optinose's Xhance with the stock down 31% following this morning's earnings report. There is understandably some concern that the company's focus on more aggressive co-pay assistance may hurt the drug's average selling price and the growth, Amsellem tells investors in an intraday research note. The analyst, however, views Optinose's transition away from the Xhance sampling program as positive and he expects the company to continue to execute on payer contracts. He lowered his price target for the shares to $30 from $34 and keeps an Overweight rating on Optinose.

TODAY'S FREE FLY STORIES

MAT

Mattel

$11.50

0.105 (0.92%)

, WMT

Walmart

$119.44

-0.08 (-0.07%)

06:24
10/17/19
10/17
06:24
10/17/19
06:24
Periodicals
Walmart, Mattel 'lease floors' in KidHQ interactive store, WSJ reports »

Mattel (MAT) and Walmart…

MAT

Mattel

$11.50

0.105 (0.92%)

WMT

Walmart

$119.44

-0.08 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 13

    Nov

  • 14

    Nov

CXP

Columbia Property

$20.31

0.05 (0.25%)

06:24
10/17/19
10/17
06:24
10/17/19
06:24
Downgrade
Columbia Property rating change  »

Columbia Property…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 12

    Nov

GTLS

Chart Industries

$58.79

-0.38 (-0.64%)

06:23
10/17/19
10/17
06:23
10/17/19
06:23
Earnings
Chart Industries sees FY20 adjusted EPS $4.75-$5.25, consensus $5.06 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 14

    Nov

AAPL

Apple

$234.59

-0.67 (-0.28%)

06:22
10/17/19
10/17
06:22
10/17/19
06:22
Recommendations
Apple analyst commentary  »

Apple price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

GTLS

Chart Industries

$58.79

-0.38 (-0.64%)

06:21
10/17/19
10/17
06:21
10/17/19
06:21
Earnings
Chart Industries lowers 2019 non-GAAP EPS view to $2.70-$2.90 from $2.85-$3.20 »

Consensus for 2019 EPS is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 14

    Nov

WLL

Whiting Petroleum

$6.65

-0.07 (-1.04%)

06:20
10/17/19
10/17
06:20
10/17/19
06:20
Downgrade
Whiting Petroleum rating change  »

Whiting Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 06

    Nov

LILA

Liberty Latin America

$18.14

0.14 (0.78%)

06:20
10/17/19
10/17
06:20
10/17/19
06:20
Upgrade
Liberty Latin America rating change  »

Barclays upgrades Liberty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$259.78

1.95 (0.76%)

06:19
10/17/19
10/17
06:19
10/17/19
06:19
Periodicals
Tesla granted car manufacturing certificate in China, Reuters reports »

China's industry…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CXP

Columbia Property

$20.31

0.05 (0.25%)

06:19
10/17/19
10/17
06:19
10/17/19
06:19
Downgrade
Columbia Property rating change  »

Columbia Property…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 12

    Nov

GTLS

Chart Industries

$58.79

-0.38 (-0.64%)

06:18
10/17/19
10/17
06:18
10/17/19
06:18
Earnings
Chart Industries reports Q3 adjusted EPS 77c, consensus 77c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 14

    Nov

JNJ

Johnson & Johnson

$135.20

2.36 (1.78%)

, TEVA

Teva

$6.94

-0.02 (-0.29%)

06:17
10/17/19
10/17
06:17
10/17/19
06:17
Periodicals
J&J offers to pay $4B to settle opioid litigation, WSJ reports »

Johnson & Johnson…

JNJ

Johnson & Johnson

$135.20

2.36 (1.78%)

TEVA

Teva

$6.94

-0.02 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

TELNY

Telenor

$0.00

(0.00%)

06:15
10/17/19
10/17
06:15
10/17/19
06:15
Downgrade
Telenor rating change  »

Telenor downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

UN

Unilever; also tag UL

$59.71

1.25 (2.14%)

, UL

Unilever; also tag UN

$59.40

1 (1.71%)

06:14
10/17/19
10/17
06:14
10/17/19
06:14
Periodicals
Unilever cuts prices in U.S. amid shampoo rivalry with P&G, WSJ reports »

Unilever (UN, UL) CFO…

UN

Unilever; also tag UL

$59.71

1.25 (2.14%)

UL

Unilever; also tag UN

$59.40

1 (1.71%)

PG

Procter & Gamble

$116.77

0.3 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 22

    Oct

NTRA

Natera

$36.30

-2.915 (-7.43%)

06:14
10/17/19
10/17
06:14
10/17/19
06:14
Syndicate
Natera 5.71M share Secondary priced at $35.00 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

NTRA

Natera

$36.30

-2.915 (-7.43%)

06:14
10/17/19
10/17
06:14
10/17/19
06:14
Syndicate
Natera 5.714M share Secondary priced at $35.00 »

JPMorgan, Morgan Stanley,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

NFLX

Netflix

$286.83

2.59 (0.91%)

, DIS

Disney

$130.95

1.18 (0.91%)

06:12
10/17/19
10/17
06:12
10/17/19
06:12
Downgrade
Macquarie downgrades Netflix to Neutral on slowing U.S. growth »

Macquarie analyst Tim…

NFLX

Netflix

$286.83

2.59 (0.91%)

DIS

Disney

$130.95

1.18 (0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 29

    Oct

  • 07

    Nov

NFLX

Netflix

$286.83

2.59 (0.91%)

06:12
10/17/19
10/17
06:12
10/17/19
06:12
Recommendations
Netflix analyst commentary  »

Netflix remains long-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

MUX

McEwen Mining

$1.50

0.015 (1.01%)

06:12
10/17/19
10/17
06:12
10/17/19
06:12
Hot Stocks
McEwen Mining reports Q3 production 45,930 gold equivalent ounces »

McEwen Mining reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IGLD

Internet Gold

$18.90

(0.00%)

06:08
10/17/19
10/17
06:08
10/17/19
06:08
Hot Stocks
Internet Gold sees Searchlight Transaction closing on November 7 »

Internet Gold announced,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STI

SunTrust

$68.28

0.23 (0.34%)

06:07
10/17/19
10/17
06:07
10/17/19
06:07
Earnings
SunTrust reports Q3 EPS $1.34, consensus $1.41 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 12

    Nov

ERIC

Ericsson

$8.63

0.175 (2.07%)

06:07
10/17/19
10/17
06:07
10/17/19
06:07
Conference/Events
Ericsson to host investor update conference call »

Conference call to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

UNTY

Unity Bancorp

$21.12

-0.45 (-2.09%)

06:06
10/17/19
10/17
06:06
10/17/19
06:06
Earnings
Breaking Earnings news story on Unity Bancorp »

Unity Bancorp reports Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$9.06

-0.02 (-0.22%)

, AMZN

Amazon.com

$1,777.43

8.73 (0.49%)

06:06
10/17/19
10/17
06:06
10/17/19
06:06
Hot Stocks
Ford introduces North America's largest electric vehicle charging network »

Ford (F) is offering its…

F

Ford

$9.06

-0.02 (-0.22%)

AMZN

Amazon.com

$1,777.43

8.73 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 21

    Nov

CREE

Cree

$47.37

-1.38 (-2.83%)

06:06
10/17/19
10/17
06:06
10/17/19
06:06
Recommendations
Cree analyst commentary  »

Cree guidance to miss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 30

    Oct

WNS

WNS Holdings

$60.62

0.85 (1.42%)

06:04
10/17/19
10/17
06:04
10/17/19
06:04
Earnings
WNS Holdings sees FY20 adjusted EPS $2.93-$3.08, consensus $2.88 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 11

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.